What cardiac defects are associated with congenital rubella syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cardiac Defects Associated with Congenital Rubella Syndrome

Congenital rubella syndrome (CRS) is most commonly associated with patent ductus arteriosus (PDA), pulmonary artery stenosis, and atrial or ventricular septal defects, with branch pulmonary artery stenosis actually being more prevalent than PDA in catheterization-confirmed cases.

Primary Cardiac Manifestations of CRS

The cardiac defects associated with congenital rubella syndrome include:

Most Common Defects

  • Branch pulmonary artery stenosis (78% of catheterization-confirmed cases) 1
  • Patent ductus arteriosus (PDA) (62% of cases) 1, 2
  • Peripheral pulmonary stenosis 2
  • Ventricular septal defects (VSD) 2, 3
  • Atrial septal defects (ASD) 2, 3

Pattern of Occurrence

  • Combined branch pulmonary artery stenosis and PDA (49% of cases) 1
  • Isolated branch pulmonary artery stenosis (29% of cases) 1
  • Isolated PDA (13% of cases) 1

Clinical Significance and Complications

  • Pulmonary hypertension: Often develops progressively in CRS patients with PDA and is associated with significantly higher mortality (p=0.004) 4
  • Tubular-type PDA: More common in CRS (16%) compared to non-CRS PDA (3%), requiring more cautious device selection for transcatheter closure 5
  • Systemic hypertension: More frequent in CRS-associated PDA cases 5
  • Mortality risk: Higher among CRS patients with complex cardiac defects (HR = 2.04,95% CI: 1.26-3.30) 3

Unique Characteristics of CRS-Associated Cardiac Defects

  • CRS patients with PDA typically have:

    • Lower birth weight
    • Higher main pulmonary artery pressure
    • Higher aortic pressure in systole/diastole
    • More frequent concurrent pulmonary and aortic stenosis 5

  • CRS cases show higher odds of left-to-right shunt lesions (OR = 1.58,95% CI: 1.15-2.17), particularly PDA (OR = 1.77,95% CI: 1.42-2.21) 3

Management Considerations

  • Early detection and timely intervention for cardiovascular defects is critical for CRS patient management 4
  • Echocardiography has both diagnostic and prognostic value in managing CRS-associated cardiac defects 4
  • Therapeutic closure of PDA can reverse pulmonary hypertension in some cases 4
  • More cautious device selection is needed for transcatheter PDA closure in CRS patients due to the higher prevalence of tubular-type PDA 5

Clinical Pitfalls and Caveats

  • While earlier literature emphasized PDA as the primary cardiac manifestation of CRS, more detailed studies using cardiac catheterization have shown that branch pulmonary artery stenosis is actually more common 1
  • Clinical evaluations for suspected CRS should include examinations for both branch pulmonary artery stenosis and PDA 1
  • Mild cardiac involvement may not be detected until months or years after birth 2
  • The combination of cardiac defects in CRS often leads to more severe outcomes than isolated defects 4

Understanding these cardiac manifestations is crucial for early detection, appropriate management, and improved outcomes in patients with congenital rubella syndrome.

References

1
Research

An update on cardiovascular malformations in congenital rubella syndrome.

Birth defects research. Part A, Clinical and molecular teratology, 2010

2
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the treatment for a patient with a vitamin B12 (cobalamin) level at the lower end of the normal range, specifically 150 picograms per milliliter (pg/mL)?
What is the proper approach to counseling a patient about erectile dysfunction (ED) drugs, including risks and contraindications?
What are the potential interactions between Trileptal (Oxcarbazepine), Effexor (Venlafaxine), Mounjaro (Tirzepatide), and Lisinopril?
What is the management for a patient with thrombocytopenia (low platelet count) presenting with a hematoma over the buccal mucosa?
What are the recommendations for using Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in patients with intracranial hypertension?
What's the next best psychopharmacological option for a patient with insomnia, ruminative thoughts, and anxiety not responding to sertraline (sertraline)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question